申请人:Eisai Co., Ltd.
公开号:EP0889032A1
公开(公告)日:1999-01-07
Fused-ring carboxylic acid derivatives represented by general formula (A) and pharmacologically acceptable salts thereof, which can provide medicines excellent in retinoic acid receptor agonist activities, wherein the symbolrepresents a single or double bond; and each of X, Y, Z, P, Q, U, V and W represents -O-, -S- or a group represented by formula (a), wherein Rk (k:1-8) represents hydrogen, halogeno, optionally substituted lower alkyl, etc., and either R7 or R8 represents a group represented by formula (b), wherein rings A and B represent each independently an optionally substituted aromatic hydrocarbon or unsaturated heterocyclic ring; and D represents an optionally protected carboxyl group.
通式(A)代表的融合环羧酸衍生物及其药理学上可接受的盐,可提供维甲酸受体激动剂活性极佳的药物,其中符号代表单键或双键;X、Y、Z、P、Q、U、V 和 W 各自代表-O-、-S- 或式(a)代表的基团,其中 Rk (k:1-8) 代表氢、卤素、任选取代的低级烷基等、以及 R7 或 R8 代表由式(b)表示的基团,其中环 A 和 B 各自独立地代表任选取代的芳香烃或不饱和杂环;以及 D 代表任选保护的羧基。